Detalles de la búsqueda
1.
Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV.
J Antimicrob Chemother
; 75(10): 2986-2993, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32737511
2.
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens.
Int J Antimicrob Agents
; 60(3): 106631, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35787920
Resultados
1 -
2
de 2
1
Próxima >
>>